GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Common Stock

Progen Co (XKRX:296160) Common Stock : ₩10,457 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Progen Co Common Stock?

Progen Co's quarterly common stock increased from . 20 (₩0 Mil) to Dec. 2023 (₩8,485 Mil) and increased from Dec. 2023 (₩8,485 Mil) to Dec. 2024 (₩10,457 Mil).

Progen Co's annual common stock stayed the same from . 20 (₩0 Mil) to . 20 (₩0 Mil) but then increased from . 20 (₩0 Mil) to Dec. 2023 (₩8,485 Mil).


Progen Co Common Stock Historical Data

The historical data trend for Progen Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progen Co Common Stock Chart

Progen Co Annual Data
Trend Dec23
Common Stock
8,485.29

Progen Co Quarterly Data
Dec23 Dec24
Common Stock 8,485.29 10,457.12

Progen Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Progen Co Business Description

Traded in Other Exchanges
N/A
Address
172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.

Progen Co Headlines

No Headlines